Wealth management firm Wilmington Trust recently published its 2023 outlook, Capital Markets Forecast (CMF), Inflationary Vortex. Life Risk News’ Greg Winterton spoke to Meghan Shue, Head of Investment Strategy at Wilmington Trust, about that report and their views on the outlook for the life settlement market this year.
Insurers are favouring funded re as it helps firms manage the market and longevity risks associated with writing bulk purchase annuity (BPA) business by reducing capital charges and therefore making PRT deals more competitive.
Unsurprisingly, given its growth and potential for capital optimisation, UK regulators have been carefully watching the increased use of funded re. In June 2023, the Prudential Regulatory Authority (PRA) sent a “Dear CRO’ letter to heads of risk at UK life insurers.
The letter outlined the regulator’s two main concerns from a sectoral review which it had carried out.
“One of the key risks arising in funded re is that firms recapture sub-optimal portfolios with depressed values and with limited ability to be transformed effectively to the firms’ preferred portfolio,” the PRA letter said.
Post a comment
Related Posts
Investor Education a Perpetual Requirement for the Life Settlement Market – But Necessary to Support Growth
The life settlement market, in its current form, is approximately 25 years old; in November…
UK Pension Risk Transfer Market Urged to Heighten Focus on Cybersecurity Diligence
The increasing frequency and magnitude of cyber-attacks on British businesses have prompted the UK’s pensions…
New Research Shows the Potential Extent of the Impact of GLP-1 Drugs on Mortality
The widespread adoption of GLP-1 weight-loss drugs could reduce mortality rates in the coming decades,…
Are We Still Living Longer? What Longevity Trends Mean for Pensions and Insurers
Over the last two centuries, average lifespans have doubled. For pension schemes, insurers and policymakers,…
